AEYE Health 
AEYE-DS is an FDA-cleared autonomous AI for diabetic retinopathy screening. Staff capture one image per eye without dilation, and the AI detects more-than-mild diabetic retinopathy (mtmDR) and gives the result during the same visit.
AEYE-DS
AI diabetic retinopathy screening - 1 minute, portable, during the visit
AEYE-DS is the only FDA-cleared portable autonomous AI, and the only solution requiring one image per eye, bringing the diabetic eye exam into the point-of-care visit. Capture one image per eye, without dilation, deliver an instant AI diagnosis, and close care gaps with automated EHR documentation.
92–93%
Sensitivity
89–94%
Specificity
>99%
Imageability
1-Min
Exam time
How AEYE-DS delivers 1-minute AI diabetic retinopathy screening
AEYE-DS runs autonomous AI DR screening and detects more-than-mild diabetic retinopathy (mtmDR) at
the point of care. Driven by native EHR integration, replacing specialist referrals and instantly closing the care gap.
1. Automated screening Alert
EHR flags patients due for screening during check-in.
2. Image Capture
Staff capture 1 image per-eye using a portable or tabletop camera with no dilation.
3. Instant AI Diagnosis
Autonomous AI generates on-the-spot results in seconds, enabling providers to discuss results with patients in the visit.
4. Closed Gap & Billing
HEDIS EED and MIPS 117 are documented automatically in the EHR, CPT 92229 billing is triggered.
Fully Integrated with Your EHR
AEYE-DS integrates directly to major EHRs, automating care gap identification, diagnostic filing, and billing triggering without manual overhead.
Trusted integrations across the continuum of care
Two ways to deploy
Choose the camera that fits your clinical needs
Flexible hardware options designed for different patient volumes and clinical settings.
AEYE-DS with the Aurora - the only portable solution
The first and only FDA-cleared autonomous AI on a handheld camera. Fast, flexible, and easy to move between rooms or sites. Ideal for primary care, mobile screening, and space-constrained clinics.
- Sensitivity
- 92% to 93%
- Specificity
- 89% to 94%
- Imageability
- More than 99%
AEYE-DS with a robotic tabletop camera (Topcon NW400)
A robotic tabletop camera that captures images with minimal operator effort, for higher-volume sites that prefer a fixed station.
- Sensitivity
- 93%
- Specificity
- Over 91%
- Imageability
- More than 99%
A quality intervention that pays for itself
AEYE-DS is one of the few quality interventions that improve clinical performance and generate revenue at the same visit.
Capture missed reimbursement
Billable under CPT 92229 across Medicare, Medicaid, and commercial plans. Autonomous AI means no reading fees, so you keep 100% of the reimbursement.
Boost HEDIS & Star ratings
Instantly satisfies the HEDIS Eye Exam for Patients with Diabetes (EED) measure, closing the gap on the spot to elevate quality scores.
Protect MIPS 117 incentives
Satisfies MIPS Quality Measure 117 on the spot with real-time EHR filing, eliminating negative Medicare payment penalties.
Trusted by clinical, quality, and operations leaders
"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."
FAQ
Turn every routine diabetic
visit into a completed eye exam
See how AEYE-DS fits your clinic’s workflow. Meet with a product expert to get started.